실험용 페트리 접시 시장 : 세계 예측(2026-2032년)

The Laboratory Petri Dishes Market is projected to grow by USD 5.08 billion at a CAGR of 5.28% by 2032.

Laboratory Petri Dishes: Executive Summary

Laboratory Petri dishes are foundational consumables used for culturing, isolating, observing, and testing microorganisms, cells, tissues, and other biological samples. Demand is shaped by research activity, clinical microbiology, pharmaceutical development, food and environmental testing, education, and quality-control workflows. Product selection commonly depends on material, sterility, size, surface treatment, venting, compartmentalization, and compatibility with automated or specialized laboratory procedures.

Laboratory Workflows Are Becoming More Specialized and Quality-Driven

The landscape is shifting toward greater specialization, reproducibility, and operational efficiency. Laboratories increasingly distinguish between glass and disposable plastic formats, sterile and nonsterile products, treated and untreated surfaces, and standard versus application-specific designs. Regulatory expectations, contamination control, traceability, and dependable supply are also becoming more important as laboratories manage sensitive assays and standardized protocols.

Sustainability is another material consideration. Users are evaluating resin selection, packaging reduction, recycling feasibility, sterilization requirements, and the trade-offs between reusable and single-use formats. These priorities vary by application and infrastructure, so product performance and validated workflow compatibility remain central to purchasing decisions.

Artificial Intelligence Improves Selection, Imaging, and Laboratory Operations

Artificial intelligence is influencing Petri-dish-related workflows primarily through laboratory automation, image analysis, and decision support rather than through the dish itself. Machine-learning systems can assist with colony counting, morphology classification, contamination detection, growth tracking, and image standardization. These applications may reduce manual review and improve consistency when supported by suitable imaging hardware, validated training data, and controlled experimental conditions.

AI also contributes to inventory planning, protocol optimization, and anomaly detection across laboratory information systems. However, implementation requires attention to data quality, model validation, cybersecurity, interoperability, and human oversight. Physical consumables must still meet sterility, dimensional, optical, and surface-performance requirements for automated systems to produce reliable results.

Regional Insights: Adoption Reflects Research Capacity and Laboratory Infrastructure

North America combines extensive pharmaceutical, biotechnology, clinical, academic, and food-testing activity with strong emphasis on quality systems, automation, and supply continuity. Europe places substantial weight on laboratory standards, sustainability, traceability, and harmonized regulatory practices. Asia-Pacific spans advanced research ecosystems and rapidly developing laboratory capacity, with demand influenced by biomanufacturing, diagnostics, education, and public-health investment.

Latin America is supported by clinical, agricultural, food, environmental, and academic testing, while procurement conditions and import dependence can affect product availability. The Middle East is developing research, healthcare, food-safety, and environmental-testing capabilities, with infrastructure investment shaping adoption. Africa presents varied laboratory maturity across countries; public-health programs, universities, agriculture, mining-related environmental testing, and local distribution networks are important drivers.

Group Insights: Trade, Regulation, and Security Shape Procurement

ASEAN reflects diverse laboratory capabilities and expanding activity in healthcare, food testing, manufacturing, and research, making distribution flexibility and application-specific training important. BRICS economies encompass large and varied research, industrial, agricultural, and public-health systems, with procurement influenced by domestic manufacturing priorities and cross-border trade conditions. The European Union emphasizes harmonized standards, sustainability, documentation, and laboratory quality practices.

The G7 generally combines mature research infrastructure with high expectations for validation, automation compatibility, and responsible procurement. GCC countries are strengthening healthcare, food-safety, environmental, and biotechnology capabilities, often alongside major infrastructure programs. NATO members include varied laboratory markets, but resilience, biosafety, preparedness, interoperability, and dependable supply chains are recurring strategic considerations.

Country Insights: Diverse Applications Require Localized Strategies

Australia applies Petri dishes across medical research, agriculture, food safety, environmental science, and education. Brazil combines substantial clinical, agricultural, industrial, and academic testing needs, while Mexico is supported by healthcare, food, manufacturing, and environmental laboratories. Canada has strong research, clinical, food, and natural-resource testing activity. China and India feature broad demand across biotechnology, diagnostics, pharmaceuticals, education, agriculture, and public-health programs.

Japan and South Korea emphasize precision, automation, advanced research, and high-quality manufacturing environments. In Europe, France, Germany, Italy, Spain, and the United Kingdom combine established academic, clinical, industrial, and food-testing ecosystems with rigorous quality expectations. Russia's requirements span healthcare, agriculture, research, and industrial testing, with procurement also affected by local production, logistics, and trade conditions. The United States supports extensive use across biotechnology, pharmaceuticals, clinical laboratories, universities, food testing, and environmental applications.

Actions for Leaders: Secure Quality, Workflow Fit, and Supply Resilience

Industry leaders should segment products by application instead of treating Petri dishes as interchangeable commodities. Priorities include validated sterility, consistent dimensions, surface performance, optical clarity where imaging is used, packaging integrity, and compatibility with manual or automated protocols. Clear technical documentation and lot-level traceability can strengthen customer confidence.

Organizations should also build resilient sourcing through qualified alternatives, regional distribution, demand monitoring, and supplier audits. Sustainability programs should assess the full use cycle, including materials, packaging, sterilization, transport, disposal, and reuse feasibility. Finally, leaders should prepare for AI-enabled laboratories by supporting machine-vision compatibility, standardized product geometry, high-quality metadata, and human review of automated outputs.

Research Methodology: Evidence-Based Synthesis of Market Structure and Use Cases

This executive summary uses a structured qualitative approach focused on the role of laboratory Petri dishes across research, clinical, pharmaceutical, food, environmental, educational, and industrial workflows. The assessment considers product attributes, purchasing criteria, laboratory infrastructure, regulation, sustainability, automation, and regional operating conditions.

Insights are organized across the specified regions, economic and institutional groups, and countries. The analysis avoids market estimates, market sizing, market shares, and forecasts, and instead synthesizes observable application requirements, workflow trends, procurement considerations, and technology influences. Country and group comparisons are directional and reflect differences in laboratory ecosystems, standards, infrastructure, and supply-chain conditions.

Conclusion: Reliable Consumables Remain Central to Modern Biological Testing

Laboratory Petri dishes remain essential to a wide range of biological and analytical procedures, even as laboratories become more automated, specialized, and data-driven. Competitive differentiation increasingly depends on reproducibility, sterility assurance, application fit, documentation, sustainability, and dependable availability rather than on basic container function alone.

The strongest strategies will align product design and supply networks with regional laboratory realities, evolving quality expectations, and AI-supported workflows. Leaders that combine validated performance with resilient distribution, responsible materials management, and practical automation compatibility will be better positioned to support laboratories across diverse global applications.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Laboratory Petri Dishes Market, by Material

• 7.1. Introduction
• 7.2. Borosilicate Glass
• 7.3. Polystyrene

8. Laboratory Petri Dishes Market, by Type

• 8.1. Introduction
• 8.2. Divided Dish
• 8.3. Multiwell Plates
• 8.4. Single-Wall Dish

9. Laboratory Petri Dishes Market, by Sterility

• 9.1. Introduction
• 9.2. Non-Sterile
• 9.3. Sterile

10. Laboratory Petri Dishes Market, by Application

• 10.1. Introduction
• 10.2. Cell Culture
• 10.3. Microbiology

11. Laboratory Petri Dishes Market, by End User

• 11.1. Introduction
• 11.2. Academic And Research Institutes
• 11.3. Food And Beverage Testing Labs
• 11.4. Hospitals And Clinics
• 11.5. Pharma And Biotechnology Companies

12. Laboratory Petri Dishes Market, by Region

• 12.1. Introduction
• 12.2. Asia-Pacific
• 12.3. North America
• 12.4. Latin America
• 12.5. Europe
• 12.6. Middle East
• 12.7. Africa

13. Laboratory Petri Dishes Market, by Group

• 13.1. Introduction
• 13.2. ASEAN
• 13.3. GCC
• 13.4. European Union
• 13.5. BRICS
• 13.6. G7
• 13.7. NATO

14. Laboratory Petri Dishes Market, by Country

• 14.1. Introduction
• 14.2. United States
• 14.3. Canada
• 14.4. Mexico
• 14.5. Brazil
• 14.6. United Kingdom
• 14.7. Germany
• 14.8. France
• 14.9. Russia
• 14.10. Italy
• 14.11. Spain
• 14.12. China
• 14.13. India
• 14.14. Japan
• 14.15. Australia
• 14.16. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2025
• 15.2. Market Concentration Analysis, 2025
  • 15.2.1. Concentration Ratio (CR)
  • 15.2.2. Herfindahl Hirschman Index (HHI)
• 15.3. Recent Developments & Impact Analysis, 2025
• 15.4. Product Portfolio Analysis, 2025
• 15.5. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Abdos Labtech Private Limited
• 16.2. Agar Scientific Ltd.
• 16.3. Avantor Inc.
• 16.4. Becton, Dickinson and Company
• 16.5. Borosil Limited
• 16.6. CELLTREAT Scientific Products Inc.
• 16.7. Corning Incorporated
• 16.8. DWK Life Sciences GmbH
• 16.9. Eisco Scientific LLC
• 16.10. F.L. Medical S.r.l.
• 16.11. GPR Tech Diagno Plastics Pvt. Ltd.
• 16.12. Greiner AG
• 16.13. Kimble Chase Life Science and Research Products LLC
• 16.14. Medasus Healthcare Pvt. Ltd.
• 16.15. Merck KGaA
• 16.16. Multigate Medical Products Pty Ltd.
• 16.17. NEST Biotechnology Co. Ltd.
• 16.18. Pall Corporation
• 16.19. Phoenix Instrument GmbH
• 16.20. Plasti Lab SARL
• 16.21. ratiolab GmbH
• 16.22. SARSTEDT AG & Co. KG
• 16.23. Schott AG
• 16.24. Thermo Fisher Scientific Inc.
• 16.25. TPP Techno Plastic Products AG

17. Key Experts